ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
Lymphoid Leukemia
B-Cell Chronic Lymphocytic Leukemia
Cancer

Non-Hodgkin Lymphoma trials near Columbus, OH, USA:

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma (BELINDA)

to Standard Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracyc...

Active, not recruiting
Non-Hodgkin Lymphoma
Drug: Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy
Drug: Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and autologous hematopoietic stem cell transplant (HSCT)

Phase 3

Novartis
Novartis

Columbus, Ohio, United States and 66 other locations

Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...

Active, not recruiting
Non Hodgkin Lymphoma
Drug: acalabrutinib
Drug: rituximab (IV)

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

Columbus, Ohio, United States and 31 other locations

CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...

Enrolling
Refractory B-Cell Non-Hodgkin Lymphoma
B Cell Lymphoma
Genetic: CB-010
Drug: Cyclophosphamide

Phase 1

Caribou Biosciences

Columbus, Ohio, United States and 29 other locations

who have received chimeric antigen receptor (CAR) T cell therapy for non-Hodgkins lymphoma and in whom have had a sub-opti...

Enrolling
B-Cell Non-Hodgkin Lymphoma-Recurrent
Primary Mediastinal Large B-Cell Lymphoma-Refractory
Procedure: Biopsy
Procedure: Computed Tomography

Phase 1

Nathan Denlinger

Columbus, Ohio, United States

The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK), immunogenicity and preliminary efficacy of VAY736 alone or in...

Enrolling
Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
Drug: VAY736
Drug: lenalidomide

Phase 1

Novartis
Novartis

Columbus, Ohio, United States and 19 other locations

given together with obinutuzumab in treating patients with B-cell non-Hodgkin lymphoma that has returned after a period of...

Active, not recruiting
Refractory Burkitt Lymphoma
Recurrent Burkitt Lymphoma
Drug: Venetoclax
Drug: Lenalidomide

Phase 1

Beth Christian

Columbus, Ohio, United States and 1 other location

clinical trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two...

Enrolling
Non Hodgkin Lymphoma
Drug: Rituximab
Drug: Cyclophosphamide

Phase 1, Phase 2

Artiva Biotherapeutics

Columbus, Ohio, United States and 20 other locations

This phase II trial studies how well nivolumab works with the DA-REPOCH chemotherapy regimen in treating patients with aggressive B-cell non-...

Active, not recruiting
Transformed Non-Hodgkin Lymphoma
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
Drug: Doxorubicin Hydrochloride
Drug: Etoposide

Phase 2

David Bond, MD

Columbus, Ohio, United States

bispecific antibody, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) who have received 2 or mo...

Enrolling
B-cell Non Hodgkin Lymphoma
Follicular Lymphoma
Drug: AZD0486 IV

Phase 1

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 28 other locations

nivolumab and to see how well they work in treating patients with non-Hodgkin or Hodgkin lymphoma that has come b...

Active, not recruiting
Refractory Burkitt Lymphoma
Recurrent Burkitt Lymphoma
Drug: Lenalidomide
Other: Laboratory Biomarker Analysis

Phase 1, Phase 2

David Bond, MD

Columbus, Ohio, United States and 1 other location

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems